In subjects with T2DM, weekly administration of tirzepatide at doses of 5 mg, 10 mg, or 15 mg was associated with greater weight loss compared to placebo ( 6.3 kg, 8.4 kg, and 9.4 kg, respectively), and 1.7 kg, 4.8 kg, and 7.2 kg greater weight loss compared to selective GLP-1 receptor agonists, demonstrating a dose-dependent effect sustained for up to 2 years [48]
Your information is protected through a secure, HIPAA-compliant platform
Looking ahead: For now, semaglutide is having a moment and that moment is reshaping both clinical care and public expectations about whats possible in treating obesity and diabetes
Check Out Our Other Services Choose which injectable vitamin best fits your health and wellness needs Explore Vitatherapy's wide range of IV treatments
Do you offer memberships
Gels vs